PharmaTher Asks FDA to Fast Track Ketamine Drug for Parkinson’s

1 year ago 150

Debra Borchardt

Debra Borchardt is the Co-Founder, and Executive Editor of GMR. She has covered the cannabis industry for several years at Forbes, Seeking Alpha and TheStreet. Prior to becoming a financial journalist, Debra was a Vice President at Bear Stearns where she held a Series 7 and Registered Investment Advisor license. Debra has a Master's degree in Business Journalism from New York University.

Get the latest cannabis news delivered right to your inbox

The Morning Rise

Unpack the industry with the daily cannabis newsletter for business leaders.

 Sign up


Warning: Invalid argument supplied for foreach() in /home/greenmarket/public_html/wp-content/plugins/bold-news/bold-news.php on line 2091

Read Entire Article
  3. PharmaTher Asks FDA to Fast Track Ketamine Drug for Parkinson’s

Related

FDA nod fuels Filament’s psychedelics push, but cash running short

FDA nod fuels Filament’s psychedelics push, but cash running short

$6M bankrolls Enveric pipeline partnering, depression program

$6M bankrolls Enveric pipeline partnering, depression program

Well-funded Alto Neuroscience’s losses widen in the first quarter

Well-funded Alto Neuroscience’s losses widen in the first quarter